[1] Simmons K, Michels AW. Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease[J]. Rheum Dis Clin North Am, 2014, 40(4):797-811.
[2] Liu R, Lee K, He JC.Genetics and epigenetics of diabetic nephropathy[J].Kidney Dis, 2015, 1(1):42-51.
[3] Mudaliar H, Pollock C, Ma J, et al.The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose[J].PLoS One, 2014, 9(10):e108844.
[4] Adamczak DM, Nowak JK, Frydrychowicz M, et al.The role of Toll-like receptors and vitamin D in diabetes mellitus type 1-a review[J].Scand J Immunol, 2014, 80(2):75-84.
[5] Medzhitov R, Preston-Hurlburt P, Janeway CA.A human homologue of the drosophila toll protein signals activation of adaptive immunity[J].Nature, 1997, 388(6640):394-397.
[6] Lin M, Tang SC.Toll-like receptors:sensing and reacting to diabetic injury in the kidney[J].Nephrol Dial Transplant, 2014, 29(4):746-754.
[7] Kokkinopoulos I, Jordan WJ, Ritter MA.Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes[J].Mol Immunol, 2005, 42(8):957-968.
[8] Grieco FA, Vendrame F, Spagnuolo I, et al.Innate immunity and the pathogenesis of type 1 diabetes[J].Semin Immunopathol, 2011, 33(1):57-66.
[9] Wen L, Ley RE, Volchkov PY, et al.Innate immunity and intestinal microbiota in the development of type 1 diabetes[J].Nature, 2008, 455(7216):1109-1113.
[10] Gale EA.The rise of childhood type 1 diabetes in the 20th century[J].Diabetes, 2002, 51(12):3353-3361.
[11] Roivainen M.Enteroviruses:new findings on the role of enteroviruses in type 1 diabetes[J].Int J Biochem Cell Biol, 2006, 38(5/6):721-725.
[12] Jaidane H, Hober D.Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes[J].Diabetes Metab, 2008, 34(6 Pt 1):537-548.
[13] Elshebani A, Olsson A, Westman J, et al.Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes[J].Virus Res, 2007, 124(1/2):193-203.
[14] Serreze DV, Ottendorfer EW, Ellis TM, et al.Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets[J].Diabetes, 2000, 49(5):708-711.
[15] Tracy S, Drescher KM, Chapman NM, et al.Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes:inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence[J].J Virol, 2002, 76(23):12097-12111.
[16] Richer MJ, Horwitz MS.Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes[J].Autoimmun Rev, 2009, 8(7):611-615.
[17] Dogusan Z, Garcia M, Flamez D, et al.Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the Toll-like receptor 3 and interferon regulatory factor 3 pathways[J].Diabetes, 2008, 57(5):1236-1245.
[18] McCall KD, Thuma JR, Courreges MC, et al.Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice[J].Endocrinology, 2015, 156(2):453-461.
[19] Alkanani AK, Hara N, Lien E, et al.Induction of diabetes in the RIP-B7.1 mouse model is critically dependent on TLR3 and MyD88 pathways and is associated with alterations in the intestinal microbiome[J].Diabetes, 2014, 63(2):619-631.
[20] Kim HS, Han MS, Chung KW, et al.Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes[J].Immunity, 2007, 27(2):321-333.
[21] Kim F, Pham M, Luttrell I, et al.Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity[J].Circ Res, 2007, 100(11):1589-1596.
[22] Raveendran VV, Tan X, Sweeney ME, et al.Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells[J].Immunology, 2011, 132(4):578-588.
[23] Rajamani U, Jialal I.Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells:implications for diabetic retinopathy[J].J Diabetes Res, 2014, 2014:790902.
[24] Grishman EK, White PC, Savani RC.Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes[J].Pediatr Res, 2012, 71(6):626-632.
[25] Meyers AJ, Shah RR, Gottlieb PA, et al.Altered Toll-like receptor signaling pathways in human type 1 diabetes[J].J Mol Med (Berl), 2010, 88(12):1221-1231.
[26] Dasu MR, Devaraj S, Zhao L, et al.High glucose induces Toll-like receptor expression in human monocytes:mechanism of activation[J].Diabetes, 2008, 57(11):3090-3098.
[27] Dasu MR, Park S, Devaraj S, et al.Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice[J].Endocrinology, 2009, 150(8):3457-3464.
[28] Devaraj S, Tobias P, Kasinath BS, et al.Knockout of Toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy[J].Arterioscler Thromb Vasc Biol, 2011, 31(8):1796-1804.
[29] Devaraj S, Tobias P, Jialal I.Knockout of Toll-like receptor-4 attenuates the pro-inflammatory state of diabetes[J].Cytokine, 2011, 55(3):441-445.
[30] Devaraj S, Dasu MR, Rockwood J, et al.Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes:further evidence of a proinflammatory state[J].J Clin Endocrinol Metab, 2008, 93(2):578-583.
[31] Dasu MR, Devaraj S, Park S, et al.Increased Toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects[J].Diabetes Care, 2010, 33(4):861-868.
[32] Ladefoged M, Buschard K, Hansen AM.Increased expression of Toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes[J].APMIS, 2013, 121(6):531-538.
[33] Lin M, Yiu WH, Li RX, et al.The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy[J].Kidney Int, 2013, 83(5):887-900.
[34] Vives-Pi M, Rodríguez-Fernández S, Pujol-Autonell I.How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes:a review[J].Apoptosis, 2015, 20(3):263-272.
[35] Takata S, Sawa Y, Uchiyama T, et al.Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions[J].Acta Histochem Cytochem, 2013, 46(1):35-42.
[36] Wu C, Lv C, Chen F, et al.The function of miR-199a-5p/Klotho regulating TLR4/NF-κB p65/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism[J].Mol Cell Endocrinol, 2015, 417:84-93.
[37] Pulskens WP, Rampanelli E, Teske GJ, et al.TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury[J].J Am Soc Nephrol, 2010, 21(8):1299-1308.
[38] Wolf G, Bohlender J, Bondeva T, et al.Angiotensin Ⅱ upregulates Toll-like receptor 4 on mesangial cells[J].J Am Soc Nephrol, 2006, 17(6):1585-1593.
[39] Musumeci D, Roviello GN, Montesarchio D.An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies[J].Pharmacol Ther, 2014, 141(3):347-357. |
